T. E. Witzig Et Al. , "Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma," 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , vol.31, Illinois, United States Of America, 2013
Witzig, T. E. Et Al. 2013. Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma. 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).
Witzig, T. E., Vose, J., Zinzani, P. L., Habermann, T. M., Tuscano, J. M., Sinha, R., ... Williams, M. E.(2013). Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma . 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America
Witzig, Thomas Et Al. "Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma," 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2013
Witzig, Thomas E. Et Al. "Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma." 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2013
Witzig, T. E. Et Al. (2013) . "Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma." 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Thomas E. Witzig Et Al. }, title={Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma}, congress name={49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2013}}